July 9, 2005
For Immediate Release
Shakeout Underway in Resynchronization Device Market, According to July 2005 Issue of MedMarkets from MedMarket Diligence, LLC
FOOTHILL RANCH, CA — The market for implantable cardioverter defibrillators is a growing industry, driven by an increase in the numbers of patients needing resynchronization therapy, primarily due to aging. And yet, not all is rosy in the ICD industry as manufacturers struggle with product failures.
Recent coverage of the recalls of seven different implantable cardioverter defibrillators by Guidant has had ramifications for the market, including gains by competitors Medtronic and St. Jude Medical, and changes to the terms of Guidant's pending acquisition by J&J.
The July 2005 issue of MedMarkets reviews the status of the resynchronization device market -- its current and emerging competitors, the status of competitors' products and the future of this market.
MedMarkets is published 12 times annually by MedMarket Diligence. Coverage encompasses medical device, biotech, biomaterials and the range of technologies encompassing device market developments and analysis of Interventional Cardiology, Cardiovascular Surgery, Orthopedics/Musculoskeletal, Abdominal & Thoracic Surgery, Gynecology, Oncology, Neurology & Neurosurgery and other clinical sectors. Past coverage may be reviewed at www.mediligence.com/archive2005.html.
MedMarket Diligence provides tactical decision-making solutions on medical
technology to the medical products and investment industries. The company
MedMarkets newsletter, a monthly analysis of the market implications of new
medical technologies, and dedicated reports on technology markets. For
additional details, contact Patrick Driscoll at
email or call
949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.